Biodegradable double-j stent and method of manufacturing the same
US-2024299197-A1 · Sep 12, 2024 · US
Hyaluronic acid based copolymers
US9101697B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9101697-B2 |
| Application number | US-201414251489-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 11, 2014 |
| Priority date | Apr 30, 2004 |
| Publication date | Aug 11, 2015 |
| Grant date | Aug 11, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Hyaluronic acid (HA) conjugates or crosslinked HAs compositions for coating an implantable device are provided. The implantable device can be used for treating a disorder such as atherosclerosis, thrombosis, restenosis, high cholesterol, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, and combinations thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A hyaluronic acid (HA) conjugate comprising a moiety derived from HA and at least one component that is heparin or a moiety derived from heparin, wherein the moiety derived from HA is a HA derivatized with a reactive agent selected from the group consisting of hydrazide, aziridine, epoxide, vinyl sulphone, and bis-succinimidyl; wherein the HA conjugate is formed by coupling the moiety derived from HA and heparin or a moiety derived from heparin.…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9101697B2 cover?
- Hyaluronic acid (HA) conjugates or crosslinked HAs compositions for coating an implantable device are provided. The implantable device can be used for treating a disorder such as atherosclerosis, thrombosis, restenosis, high cholesterol, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein…
- Who is the assignee on this patent?
- Abbott Cardiovascular Systems
- What technology area does this patent fall under?
- Primary CPC classification A61L31/10. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).